Why do Most Relationships Fail? – The Myth of the Magical Other

Why do Most Relationships Fail? – The Myth of the Magical Other

academyofideas.com

Why do Most Relationships Fail?

– The Myth of the Magical Other

[embedded content]

The following is a transcript of this video.

“…more people look for salvation through relationship than in houses of worship. One may even suggest that romantic love has replaced institutional religion as the greatest motive power and influence in our lives…the search for love has replaced the search for God.”

James Hollis, The Eden Project: In Search of the Magical Other

Half of all first marriages end in divorce; as do two-thirds of second marriages, and nearly three-quarters of third marriages. Most non-marital relationships also end in separation. Of the relationships that do last, many are unhealthy and unhappy. Most relationships, in other words, fail. In some cases it is infidelity, abuse, or a clash in personality, beliefs, values, or life-plans that causes a relationship to fail. Many times, however, it is the result of one, or both partners, burdening the relationship with the fantasy that it will cure all their personal problems. This belief that a romantic relationship will unlock a life of happiness and fulfillment, the psychiatrist M. Scott Peck called the myth of romantic love. And in this video, we explain how belief in this myth destroys one’s capacity to cultivate the healthy and realistic love that sustains fulfilling relationships. For as M. Scott Peck writes:

“The myth of romantic love tells us that when we meet the person for whom we are intended…we will be able to satisfy all of each other’s needs forever and ever, and therefore live happily forever after in perfect union and harmony…While I generally find that great myths are great precisely because they represent and embody great universal truths…the myth of romantic love is a dreadful lie…as a psychiatrist I weep in my heart almost daily for the ghastly confusion and suffering that this myth fosters.”

M. Scott Peck, The Road Less Traveled

The myth of romantic love is pervasive in popular culture; countless shows, movies, plays, books, and songs are centered around the theme of a lost and lonely individual who finds the perfect romantic match, and thereafter experiences a life of happiness and fulfillment. The psychologist James Hollis called this perfect romantic match the Magical Other. And he suggested that as traditional sources of meaning such as religion, family, and community have eroded, the pursuit of the Magical Other has intensified – as many people today deify romantic love and view it as the central source of life’s meaning. Or as Hollis wrote in The Eden Project: The Search for the Magical Other:

“One of the false ideas that drives humankind is the fantasy of the Magical Other, the notion that there is one person out there who is right for us…a soul-mate who will repair the ravages of our personal history; one who will be there for us, who will read our minds, know what we want and meet those deepest needs; a good parent who will protect us from suffering and, if we are lucky, spare us the perilous journey of individuation… Virtually all popular culture is fueled by…the search for the Magical Other.”

James Hollis, The Eden Project: In Search of the Magical Other

In addition to popular culture promoting the idea that a Magical Other can save one from suffering and make life meaningful, the search for the “Magical Other” often stems from a childhood lacking in sufficient parental love, affection, and attention. A child who does not receive steady and dependable caregiving tends to develop into an adult afflicted with feelings of insecurity, a fragile identity, and pervasive feelings of emptiness. Such an individual often attempts to fill the emotional void by anchoring their sense of self in a relationship, and by seeking a romantic partner who can assume the role of a maternal or paternal figure, or as Hollis writes:

“The search for reflection from the Magical Other is also the dynamic of narcissism, which manifests in the adult who as a child was insufficiently mirrored by a loving, affirmative parent.”

James Hollis, The Eden Project: In Search of the Magical Other

In the early stages of a relationship, it can appear as if one has found their Magical Other. With dopamine and oxytocin flooding the brain, and with evolved mating instincts playing tricks on the mind so as to increase the probability of reproducing, the experience of falling in love is rife with illusions – the primary of which is the idealization of the significant other. The faults and flaws of the partner are ignored or glossed over as eccentricities which only add to their charm. The novelty of the other, coupled with their perceived perfection, engenders deep feelings of infatuation, happiness, and euphoria, which can breed the illusion that life is now complete. Furthermore, one’s ego boundaries collapse as one psychologically merges with the partner, just as in early infancy one was psychologically merged with the mother. “In some respects the act of falling in love is an act of regression.”, observed James Hollis. Or as the M. Scott Peck wrote regarding this experience:

“The unreality of these feelings when we have fallen in love is essentially the same as the unreality of the two-year-old who feels itself to be king of the family and the world with power unlimited. Just as reality intrudes upon the two-year-old’s fantasy of omnipotence so does reality intrude upon the fantastic unity of the couple who have fallen in love…One by one, gradually or suddenly, the ego boundaries snap back into place; gradually or suddenly, they fall out of love. Once again they are two separate individuals.”

M. Scott Peck, The Road Less Traveled

When reality intrudes upon the illusions of falling in love, the romantic partner, rather than being a Magical Other, is revealed as being human, all-too-human. Seen without rose colored glasses, their faults, flaws, rough edges, and bad habits grow apparent. The partner does not always make one happy, meet one’s needs, or fulfill one’s expectations; and so, in place of sustained infatuation and happiness, at times there are feelings of indifference, disappointment, and even disdain. These feelings are a normal component of long-term relationships, for as M. Scott Peck writes: “…real love often occurs in a context in which the feeling of love is lacking, when we act lovingly despite the fact that we don’t feel loving.” (M. Scott Peck, The Road Less Traveled) However, for individuals enthralled to the myth of romantic love, the conclusion of the honeymoon period, and the awareness of the widening gulf between their fantasy of who they want their partner to be, and who they really are, can be a troubling experience. Or as James Hollis writes:

“Why don’t you make me feel good about myself?” we ask, usually unconsciously but sometimes straight out. “Why don’t you meet my needs?”…What a disappointment, how unromantic – the Other was not put on earth to serve or take care of me, protect me from my life!”

James Hollis, The Eden Project: In Search of the Magical Other

Or as Hollis continues:

“…if I do not see and love my partner as a real person in the real world, if instead I elaborate a fantasy about him or her, using the person merely as a springboard for my imagination and my wishes, then I am doomed sooner or later to resent the actual person for not living up to my fantasies.”

James Hollis, The Eden Project: In Search of the Magical Other

So long as one remains captured by the myth of romantic love, and chained to search for the Magical Other, one dooms their relationships from the start. Holding onto the expectation that a romantic partner should be the primary source of life’s meaning leads to resentment and mounting pressures that either strain or break the relationship. A pathological dynamic can also develop. The individual in search of the Magical Other manipulates and controls their partner in the attempt to mold them into their idealized image; while the other partner, fearful that they will be abandoned, hopelessly strives to live up to this fantasy by submissively devoting almost all their time and energy to satiating the other’s every desire, wish, and need. Or as Hollis writes:

“[The search for the Magical Other] accounts for the fact that so many couples move from naive relatedness to the joustings of power. If you do not act as I wish, I shall bring about your compliance by my actions. I will control you, criticize you, abuse you, withdraw from you, sabotage you…And so, through tactics of dependence or anger or control, mixed with emotional and sexual withdrawal, one [of the partners] tries to force the Other back into one’s original, imaginary mold. Seldom are these attitudes and behaviors conscious.”

James Hollis, The Eden Project: In Search of the Magical Other

To avoid the unnecessary suffering that plagues so many relationships, it is critical that we discard the myth of romantic love, abandon the search for the Magical Other, and rather than seeking salvation in someone else’s affection, concentrate on cultivating self-love. For as the psychologist Nathaniel Branden wrote:

“The first love affair we must consummate successfully is the love affair with ourselves. Only then are we ready for other love relationships.”

Nathaniel Branden, The Psychology of Romantic Love

Or as M. Scott Peck observed:

“If being loved is your goal, you will fail to achieve it. The only way to be assured of being loved is to be a person worthy of love, and you cannot be a person worthy of love when your primary goal in life is to passively be loved.”

M. Scott Peck, The Road Less Traveled

One of the most effective ways to find the motivation to cultivate self-love is to recognize and accept the fact that we are, and always will be, inescapably alone. We are born alone, die alone, and though the boundaries which separate us from others can be bridged, they can never be transcended. “We are each of us, in the last analysis, islands of consciousness—and that is the root of our aloneness.”, observed James Hollis. Relationships come, and either through breakup, divorce, or death, they end, but what always remains is our individual journey – the magnum opus of our life.

“The ultimate goal of life remains the spiritual growth of the individual, the solitary journey to peaks that can be climbed only alone.”

M. Scott Peck, The Road Less Traveled

Focusing on expanding our skills, pursuing excellence in a vocation, cultivating enriching hobbies, sculpting our mind and body, creating a network of inspiring friends, seeking adventures, and devoting ourselves to rewarding goals – this is how we make our solitary journey meaningful, and therein cultivate self-love. And with sufficient self-love, we do not need a relationship to thrive, and, paradoxically, this is when we are at our most attractive and capable of cultivating a healthy relationship that is based on the following foundation of realism: A romantic partner can support us and enrich our journey, just as we can support and enrich theirs. However, to use a relationship to flee the burdens of our existence and to look to another person to provide us fulfillment, is to damage the relationship and cripple ourselves with infantile dependencies. The earthly salvation that we seek can only be found by cultivating and affirming our individual journey; it cannot be found in the arms of another.

“Those vested deeply in the idea of romance will no doubt protest, but then they will remain enslaved to the pursuit of the illusory Magical Other.”

James Hollis, The Eden Project: In Search of the Magical Other

Or as M. Scott Peck concludes:

“…it is the separateness of the partners that enriches the union. Great marriages cannot be constructed by individuals who are terrified by their basic aloneness, as so commonly is the case, and seek a merging in marriage… Two people love each other only when they are quite capable of living without each other but choose to live with each other…Genuine love not only respects the individuality of the other but actually seeks to cultivate it, even at the risk of separation or loss.

M. Scott Peck, The Road Less Traveled

Art Used in this Video




420 with CNW — Connecticut Doubles Recreational Cannabis Purchase Limit

420 with CNW — Connecticut Doubles Recreational Cannabis Purchase Limit

image

Beginning in December, adults in the state of Connecticut will be allowed to buy up to one-half an ounce of cannabis in one retail transaction. This comes after the state doubled its purchase limit from quarter of an ounce of marijuana.

The state’s Department of Consumer Protection announced the scheduled increase last week, explaining that it was the result of a continuing analysis of demand and supply and was designed to make certain businesses maintain sufficient supply for both medical cannabis patients and adult-use consumers.

It should be noted, however, that the limits imposed on medical cannabis remain unchanged.

The state department’s commissioner, Bryan T. Cafferelli, added that as more production companies, retailers and other licensees in the supply chain came online, the industry’s capacity had increased. Cafferelli noted that they were confident the measured approach to recreational sales had created a healthy market for businesses as well as a fair and safe marketplace for both medical cannabis patients and adult-use marijuana consumers.

Currently, possession of marijuana in the state is capped at one and a half ounces for adults. Adults are also allowed to store no more than five ounces in a locked trunk, glovebox or a locked container in their homes. Cafferelli also highlighted that purchased marijuana needed to remain in its original packaging and be out of reach of children.

The state legalized the recreational use of cannabis via the legislature in 2021. Since then, the state has recorded steady sales. Thus far, the adult-use market has seen a number of consecutive record-setting months of legal purchases. For instance, the state recorded $10.8 million worth of medical marijuana sales and $14.4 million in adult-use sales in September.

It is important to remember that the limits imposed on the purchase of products besides raw marijuana flower are set by equivalence.

Earlier in August, the state also launched a fund to provide support to social equity cannabis businesses. The established loan program will offer financial assistance to help individuals who have been disproportionately affected by the war on drugs to expand their businesses in this burgeoning industry.

In addition, in July of this year, the state legalized home cultivation of cannabis for personal use. It also adopted tax breaks for legal marijuana businesses in the same month. This move to help businesses that cannot make federal deductions under the IRS 280E code is expected to bring in $4.7 million in industry relief for the 2024 fiscal year. Projections from the office of the governor expect this figure to increase in the 2025 fiscal year, reaching $6.2 million.

The growth that is likely to result from this recent adjustment to how much recreational marijuana adults can buy could create opportunities for many local companies to grow to the levels experienced by companies that are licensed in other jurisdictions, such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED).

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Nova Cannabis sees increasing revenue from data licensing, private label partnerships

Nova Cannabis sees increasing revenue from data licensing, private label partnerships

Nova Cannabis Inc., a retail chain with 92 locations in three provinces, says it’s beginning to see consistent green on its spreadsheet through market stabilization, data licensing agreements, and a private label partnership with a cannabis producer. 

Nova, which has locations in Alberta, Ontario, and Saskatchewan, primarily under its Value Buds and Firesale Cannabis banners, reported net earnings of $2.1 million for Q3 2023, compared to a loss of $1.5 million for the same period in 2022.

Nova estimates its market share was approximately 19.1% in Alberta for the third quarter of 2023. Stabilization, specifically in the Alberta retail market, helped the company report record gross margins and profits, with 60 Value Buds locations listed by the Alberta cannabis regulator.

In Ontario, a market with nearly 2,000 retail stores, it estimates it has about 3.5% of the market share, with about 35 locations either approved or in the approval process.

The company reported a record gross margin of $17.0 million (25.1% of revenue), a 52.8% increase from $11.1 million for the third quarter of 2022 (18.9% of revenue), and a 16% increase from the previous quarter from $14.6 million (22.8% of revenue). 

Nova’s “data licensing program” continues to grow exponentially, with $4 million in revenue for the third quarter of 2023, compared to $1.4 million in the third quarter of 2022 and $2.7 million for the second quarter of 2023. Previously, the company expected its data licensing revenue to increase its gross margin by approximately two percentage points each quarter.

In late 2022, Nova and SNDL had a tentative agreement that would have seen SNDL hand over control of 26 cannabis stores it owned under the Spiritleaf and Superette banners located in Ontario and Alberta. SNDL would also get exclusive access to Nova’s intellectual property, such as sales data, from its Value Buds retail brand.

The two companies have been repeatedly extending the closing of that partnership due to what they say is a review by one provincial regulator. The most recent extension is to November 30, 2023.

SNDL became Nova’s majority shareholder when it acquired Alcanna in 2022, Nova’s largest shareholder at the time. Similarly, High Tide, another sizeable retail cannabis business in Canada with 156 Canna Cabana locations across the country, reported sales from its own “Cabanalytics business data and insights platform” increased to $6.5 million in the third fiscal quarter of 2023 from $5.5 million during the same period in 2022.


420 with CNW — Connecticut Doubles Recreational Cannabis Purchase Limit

420 with CNW — University of Buffalo Professor Receives $3.2M Grant to Study Cannabis Among Cancer Patients

image

The National Institutes of Health’s (NIH) National Cancer Institute has allocated $3.2 million to fund a study exploring the impact of marijuana use on cancer patients undergoing immunotherapy treatment. The grant, announced by the University of Buffalo (UB), aims to conduct a comprehensive yearlong examination of how cannabis use by cancer patients affects their response to conventional cancer treatments. Specifically, the study focuses on patients undergoing immunotherapy, a treatment known for its reduced side effects compared to chemotherapy.

Speaking at a National Academies of Sciences, Engineering, and Medicine (NASEM) meeting last month, an NCI representative expressed the organization’s desire to support studies looking into the potential benefits of cannabis use in cancer treatment. He stated that while the majority of oncologists have discussed marijuana use with patients, comparatively few were well-informed about the subject.

The study will be a collaborative effort between UB, Oregon Health and Science University, and Thomas Jefferson University. It will be conducted in three separate locations, with each site enrolling 450 cancer patients undergoing immunotherapy treatment.

Studies conducted by UB indicate that approximately 40% of cancer patients turn to marijuana as an option to alleviate pain, enhance their mood and improve sleep quality. Nevertheless, despite cancer and its treatments being qualifying conditions in a majority of states where recreational or medical marijuana use is legal, there is a paucity of long-term studies examining the potential benefits and drawbacks of marijuana use for individuals undergoing immunotherapy.

Lead researcher Rebecca Ashare expressed the need for rigorous research in this domain, stating that although some cannabinoids are known for their anti-inflammatory properties, which can be advantageous in mitigating pain, they may also exert a suppressive effect on immune function.

To conduct the study, the research team will divide the participants into two groups: marijuana users and nonusers. Over the course of one year, the researchers will analyze blood samples, patients’ outcomes and medical records at six separate intervals. The grant will also facilitate a study into the impact of neighborhood disparities on outcomes related to immunotherapy and marijuana use.

Ashare stated that the overarching goal is to significantly impact cancer-symptom-management science and ultimately improve patient care and safety. It will draw upon the collective expertise of a multidisciplinary team well-versed in various domains, including health equity, cancer symptom management, medical marijuana, oncology, substance misuse and immunology.

This study could be of great interest to marijuana businesses such as Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) because the outcome is likely to provide more information about how cancer patients undergoing immunotherapy can best benefit from medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

IM Cannabis to report third quarter 2023 financial results on Monday, Nov. 13

IM Cannabis to report third quarter 2023 financial results on Monday, Nov. 13

TORONTO and GLIL YAM, Israel — IM Cannabis Corp., a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended September 30, 2023, on Monday, November 13, 2023 before the market opens.

The company will host a zoom web conference on the same day at 9:00 a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at investors.imcannabis.com within 24 hours after the call.

Link for the zoom call: us02web.zoom.us/webinar/register/WN_4KdMNcEESymEAfNDysW-Jg.

Advertisement

Treat California Pulls Plug on 2024 Psychedelic Legalization Drive

Treat California Pulls Plug on 2024 Psychedelic Legalization Drive

A campaign that was working to legalize psychedelics in California has suspended its efforts to get a psychedelic legalization initiative on the 2024 ballot. Treat California is a citizen-driven ballot measure that would have funded the research and development of psychedelic medicines in California.

The campaign recently announced that it is pulling out of the signature-gathering process and will be focusing its attention on a recently founded nonprofit organization committed to improving mental health and well-being.

Although Californian voters have expressed major support for legalizing psychedelic research and expanding the public’s access to psychedelic-assisted treatments, recent surveys show that a majority of them do not trust state agencies to run a psychedelic program. Treat California’s ballot initiative — the Treatment, Research, Education, Access and Therapies (TREAT) California Act — would have created a $5 billion state agency and tasked it with promoting and funding research into various psychedelics.

Included in the initiative was $500 million in annual funding from government agency revenue bonds for loans and grants for psychedelic researchers.

Once it was up and running and the FDA had approved therapeutic psychedelic use, the agency would also facilitate the launch of care programs in the state for MDMA and psilocybin.

The campaign is now suspending signature-gathering efforts just a few weeks after the effort began began and redirecting its attention to Treat Humanity, a nonprofit dedicated to expanding education, research, therapies and access to treatments meant to optimize well-being and treat mental health.

The decision to suspend signature collection efforts comes shortly after FM3 Research ran a poll and found that at least 60% of Californians were not in favor of state funding being used to fund psychedelic research. According to the poll, 45% of the participants said they did not support the establishment of a state agency to develop psychedelic-assisted treatments.

Furthermore, three in every five Democrat participants supported the initiative, but most Republicans and Independents opposed the measure’s summary language.

With this poll and other factors in mind, the campaign will now work to provide solutions for mental health issues in California. Treat California CEO and Treat Humanity founder Jeannie Fontana says the entire country, not just California, is in the midst of a “mental-health catastrophe.”

Polling showed that people acknowledged the fact that America was in dire need of mental-health solutions, Fontana said, and the campaign now has the clarity it needs to work toward developing the proper solutions. She said that Treat Humanity will immediately begin engaging with the public, stakeholders, experts and elected officials to figure out a new course of action.

The role of startups such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) in accelerating public interest in psychedelics can’t be downplayed. With the passage of time, many cities and states are likely to enact reforms aimed at leveraging psychedelics in the fight against mental-health conditions. The setback in Treat California’s ballot initiative can therefore be viewed as a speed bump and not the end of the road for psychedelic reform in the Sunshine state.

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com

PsychedelicNewsWire is powered by IBN